| scholarly article | Q13442814 |
| P50 | author | Colin J. Morley | Q37830456 |
| Susan Donath | Q39438266 | ||
| Suzanne Marie Garland | Q87258284 | ||
| Sepehr N Tabrizi | Q87723657 | ||
| P2093 | author name string | Susan E Jacobs | |
| Marie Pirotta | |||
| Jacinta M Tobin | |||
| Gillian F Opie | |||
| ProPrems Study Group | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| preterm infant | Q45051448 | ||
| probiotics | Q1816730 | ||
| P304 | page(s) | 1055-1062 | |
| P577 | publication date | 2013-11-18 | |
| P1433 | published in | Pediatrics | Q7159238 |
| P1476 | title | Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial | |
| P478 | volume | 132 |
| Q40081393 | A randomized synbiotic trial to prevent sepsis among infants in rural India |
| Q39194763 | Acylcarnitine Profiles Reflect Metabolic Vulnerability for Necrotizing Enterocolitis in Newborns Born Premature |
| Q35738350 | Bacillus clausii for Prevention of Late-onset Sepsis in Preterm Infants: A Randomized Controlled Trial |
| Q40886498 | Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial |
| Q26823017 | Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut |
| Q35866688 | Buccal administration of human colostrum: impact on the oral microbiota of premature infants. |
| Q64078780 | Challenge to the Intestinal Mucosa During Sepsis |
| Q35263336 | Cochrane in context: probiotics for prevention of necrotizing enterocolitis in preterm infants |
| Q90462177 | Effect of Synthetic Vitamin A and Probiotics Supplementation for Prevention of Morbidity and Mortality during the Neonatal Period. A Systematic Review and Meta-Analysis of Studies from Low- and Middle-Income Countries |
| Q59798304 | Effects of Probiotic Supplementation on the Gut Microbiota and Antibiotic Resistome Development in Preterm Infants |
| Q47187585 | Effects of Probiotics on Necrotizing Enterocolitis, Sepsis, Intraventricular Hemorrhage, Mortality, Length of Hospital Stay, and Weight Gain in Very Preterm Infants: A Meta-Analysis |
| Q58723166 | Effects of lactoferrin on neonatal pathogens and Bifidobacterium breve in human breast milk |
| Q47919617 | Effects of probiotics on experimental necrotizing enterocolitis: a systematic review and meta-analysis |
| Q99570235 | Exploratory studies from the PiPS trial fail to find evidence that Bifidobacterium breve BBG-001 modifies intestinal barrier function |
| Q57478925 | Filling the Gaps: Current Research Directions for a Rational Use of Probiotics in Preterm Infants |
| Q59340698 | Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial |
| Q35760148 | Human milk oligosaccharides in premature infants: absorption, excretion, and influence on the intestinal microbiota |
| Q38796288 | Impact of probiotics on necrotizing enterocolitis |
| Q92266563 | Implementation of a probiotic protocol to reduce rates of necrotizing enterocolitis |
| Q35727761 | Lactation and Intestinal Microbiota: How Early Diet Shapes the Infant Gut. |
| Q28263198 | Lactobacillus reuteri DSM 17938 as a Probiotic for Preterm Neonates: A Strain-Specific Systematic Review |
| Q35550706 | Late-onset neonatal sepsis: recent developments |
| Q38347714 | Late-onset sepsis in preterm infants: update on strategies for therapy and prevention |
| Q33645689 | Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding Trials |
| Q38822502 | Microbial therapeutic interventions |
| Q33742439 | Microorganisms with claimed probiotic properties: an overview of recent literature. |
| Q38969590 | Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: An updated meta-analysis |
| Q89448019 | New insights into necrotizing enterocolitis: From laboratory observation to personalized prevention and treatment |
| Q40886491 | Not all probiotic strains prevent necrotising enterocolitis in premature infants |
| Q24185925 | Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates |
| Q64969749 | Para-probiotics for Preterm Neonates-The Next Frontier. |
| Q38663368 | Patterns of Early-Life Gut Microbial Colonization during Human Immune Development: An Ecological Perspective |
| Q30235610 | Prevention and treatment of neonatal nosocomial infections. |
| Q35922759 | Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant |
| Q64065562 | Prevention of necrotizing enterocolitis in premature infants - an updated review |
| Q37347035 | Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis |
| Q90729371 | Preventive strategies and factors associated with surgically treated necrotising enterocolitis in extremely preterm infants: an international unit survey linked with retrospective cohort data analysis |
| Q47128430 | Probiotic Supplementation in Preterm Infants Does Not Affect the Risk of Bronchopulmonary Dysplasia: A Meta-Analysis of Randomized Controlled Trials. |
| Q38607616 | Probiotic supplementation for preventing invasive fungal infections in preterm neonates--a systematic review and meta-analysis |
| Q42376142 | Probiotic supplementation in preterm infants does not affect the risk of retinopathy of prematurity: a meta-analysis of randomized controlled trials |
| Q38614389 | Probiotics Prevent Late-Onset Sepsis in Human Milk-Fed, Very Low Birth Weight Preterm Infants: Systematic Review and Meta-Analysis |
| Q42366144 | Probiotics and Innate and Adaptive Immune Responses in Premature Infants |
| Q26739951 | Probiotics and Time to Achieve Full Enteral Feeding in Human Milk-Fed and Formula-Fed Preterm Infants: Systematic Review and Meta-Analysis |
| Q37113302 | Probiotics and mastitis: evidence-based marketing? |
| Q38590665 | Probiotics and necrotizing enterocolitis |
| Q47252497 | Probiotics and necrotizing enterocolitis |
| Q27015119 | Probiotics and necrotizing enterocolitis |
| Q92241520 | Probiotics and prebiotics in clinical tests: an update |
| Q38191264 | Probiotics and prebiotics: prospects for public health and nutritional recommendations |
| Q26764805 | Probiotics for Preventing Late-Onset Sepsis in Preterm Neonates: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q92135542 | Probiotics for Prevention of Severe Necrotizing Enterocolitis: Experience of New Zealand Neonatal Intensive Care Units |
| Q64229130 | Probiotics for preterm infants - time to end all controversies |
| Q28081613 | Probiotics for prevention of necrotizing enterocolitis in preterm infants: systematic review and meta-analysis |
| Q39283163 | Probiotics for the prevention of necrotising enterocolitis in very low-birth-weight infants: a meta-analysis and systematic review |
| Q88323935 | Probiotics for the prevention of surgical necrotising enterocolitis: systematic review and meta-analysis |
| Q38520257 | Probiotics in neonatal intensive care - back to the future. |
| Q40227752 | Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants |
| Q38955406 | Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing Enterocolitis. |
| Q95725368 | Probiotics, prematurity and neurodevelopment: follow-up of a randomised trial |
| Q36058834 | Protective Effect of Dual-Strain Probiotics in Preterm Infants: A Multi-Center Time Series Analysis. |
| Q38607318 | Quantitative Risk-Benefit Analysis of Probiotic Use for Irritable Bowel Syndrome and Inflammatory Bowel Disease |
| Q40531655 | Research progress of the application of probiotics in preterm infants |
| Q52699279 | Routine Supplementation of Lactobacillus rhamnosus GG and Risk of Necrotizing Enterocolitis in Very Low Birth Weight Infants. |
| Q98778637 | Safety and efficacy of probiotic administration to preterm infants: ten common questions |
| Q54364948 | Standardized slow enteral feeding protocol reduces necrotizing enterocolitis in micropremies. |
| Q38943477 | Survey and evidence based review of probiotics used in very low birth weight preterm infants within the United States. |
| Q36280217 | The "Golden Age" of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants |
| Q64984107 | The Cross Contamination (Cross Colonization) Phenomenon of Probiotic Use in Neonatal Intensive Care Units: Putative Mechanisms and Clinical and Research Implications. |
| Q39287686 | The Microbiota of the Extremely Preterm Infant |
| Q28075770 | The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood |
| Q89305086 | The availability of probiotics and donor human milk is associated with improved survival in very preterm infants |
| Q28080685 | The human neonatal gut microbiome: a brief review |
| Q46054974 | The importance of the microbiome in pediatrics and pediatric infectious diseases |
| Q90599913 | Therapeutic Potential of the Gut Microbiota in the Management of Sepsis |
| Q58754447 | Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis |
| Q50072461 | Using probiotics to prevent necrotising enterocolitis |
| Q90587466 | Which is the best probiotic treatment strategy to prevent the necrotizing enterocolitis in premature infants: A network meta-analysis revealing the efficacy and safety |
Search more.